Presepsin Predicts 1-Year All-Cause Mortality Better Than N-Terminal Pro-B-Type Natriuretic Peptide in Patients Undergoing Transcatheter Aortic Valve Implantation

References

• Yang HS , HurM, YiA, KimH, LeeS, KimSN. Prognostic value of presepsin in adult patients with sepsis: systematic review and meta-analysis. PLOS ONE13(1), e0191486 (2018).
   PubMed Web of Science ®Google Scholar
• Sekine Y , KotaniK, OkaDet al. Presepsin as a predictor of septic shock in patients with urinary tract infection. BMC Urol.21(1), 144 (2021).
   PubMed Web of Science ®Google Scholar
• Lee S , SongJ, ParkDWet al. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions. BMC Infect. Dis.22(1), 8 (2022).
   PubMed Web of Science ®Google Scholar
• Kim CH , KimEY. Prediction of postoperative sepsis based on changes in presepsin levels of critically ill patients with acute kidney injury after abdominal surgery. Diagnostics (Basel)11(12), 2321 (2021).
   PubMedGoogle Scholar
• Maddaloni C , DeRose DU, SantisiAet al. The emerging role of presepsin (P-SEP) in the diagnosis of sepsis in the critically ill infant: a literature review. Int. J. Mol. Sci.22(22), 12154 (2021).
   PubMed Web of Science ®Google Scholar
• Popov D , PlyushchM, OvseenkoS, AbramyanM, PodshchekoldinaO, YaroustovskyM. Prognostic value of sCD14-ST (presepsin) in cardiac surgery. Kardiochir. Torakochirurgia Pol.12(1), 30–36 (2015).
   PubMedGoogle Scholar
• Bomberg H , KlingeleM, WagenpfeilSet al. Presepsin (sCD14-ST) is a novel marker for risk stratification in cardiac surgery patients. Anesthesiology126(4), 631–642 (2017).
   PubMed Web of Science ®Google Scholar
• Daniels LB , MaiselAS. Natriuretic peptides. J. Am. Coll. Cardiol.50(25), 2357–2368 (2007).
   PubMed Web of Science ®Google Scholar
• O'Sullivan CJ , StorteckyS, HegD, JuniP, WindeckerS, WenaweserP. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation. EuroIntervention10(10), e1–e8 (2015).
   PubMed Web of Science ®Google Scholar
• Mizutani K , HaraM, IwataSet al. Elevation of B-type natriuretic peptide at discharge is associated with 2-year mortality after transcatheter aortic valve replacement in patients with severe aortic stenosis: insights from a multicenter prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) registry. J. Am. Heart Assoc.6(7), e006112 (2017).
   PubMed Web of Science ®Google Scholar
• Vahanian A , BeyersdorfF, PrazFet al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J.43(7), 561–632 (2022).
   PubMed Web of Science ®Google Scholar
• Liebetrau C , HoffmannJ, DorrOet al. Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction. Circ. Res.116(5), 867–875 (2015).
   PubMed Web of Science ®Google Scholar
• Liebetrau C , GaedeL, KimWKet al. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality. Int. J. Cardiol.265, 40–46 (2018).
   PubMed Web of Science ®Google Scholar
• Kappetein AP , HeadSJ, GenereuxPet al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur. J. Cardiothorac. Surg.42(5), S45–S60 (2012).
   PubMed Web of Science ®Google Scholar
• Uhle F , CastrupC, NecaevAMet al. Inflammation and its consequences after surgical versus transcatheter aortic valve replacement. Artif. Organs42(2), e1–e12 (2018).
   PubMed Web of Science ®Google Scholar
• Reiner AP , LangeEM, JennyNSet al. Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler. Thromb. Vasc. Biol.33(1), 158–164 (2013).
   PubMed Web of Science ®Google Scholar
• Abramowitz Y , ChakravartyT, JilaihawiHet al. Impact of preprocedural B-type natriuretic peptide levels on the outcomes after transcatheter aortic valve implantation. Am. J. Cardiol.116(12), 1904–1909 (2015).
   PubMed Web of Science ®Google Scholar
• O'Neill BP , GuerreroM, ThouraniVHet al. Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER trial). Am. J. Cardiol.115(9), 1265–1272 (2015).
   PubMed Web of Science ®Google Scholar
• Vale NC , CampanteTeles R, MadeiraSet al. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation. Rev. Port. Cardiol. (Engl. Ed.)37(1), 67–73 (2018).
   PubMed Web of Science ®Google Scholar
• Takagi H , HariY, KawaiN, KunoT, AndoT, GroupA. Meta-analysis of impact of baseline N-terminalpro-brain natriuretic peptide levels on survival after transcatheter aortic valve implantation for aortic stenosis. Am. J. Cardiol.123(5), 820–826 (2019).
   PubMed Web of Science ®Google Scholar
• Libby P , NahrendorfM, SwirskiFK. Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded “cardiovascular continuum.”J. Am. Coll. Cardiol.67(9), 1091–1103 (2016).
   PubMed Web of Science ®Google Scholar
• Pai JK , PischonT, MaJet al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med.351(25), 2599–2610 (2004).
   PubMed Web of Science ®Google Scholar
• Rothenburger M , WichterT, SchmidCet al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J. Heart Lung Transplant.23(10), 1189–1197 (2004).
   PubMed Web of Science ®Google Scholar
• Gardner RS , OzalpF, MurdayAJ, RobbSD, McDonaghTA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur. Heart J.24(19), 1735–1743 (2003).
   PubMed Web of Science ®Google Scholar